Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients
نویسندگان
چکیده
منابع مشابه
Particulate matter in injectable drug products.
UNLABELLED Clinicians have had concerns about particulate matter contamination of injectable drug products since the development of the earliest intravenous therapeutics. All parenteral products contain particulate matter, and particulate matter contamination still has the potential to cause harm to patients. With tens of millions of doses of injectable drug products administered in the United ...
متن کاملhealth risks attributed to particulate matter of 2.5 microns or less in tehran air 2005-2015
abstract
متن کاملsecuritization of mortality risks in life annuities
insurers have in the past few decades faced longevity risks - the risk that annuitants survive more than expected - and therefore need a new approach to manage this new risk. in this dissertation we survey methods that hedge longevity risks. these methods use securitization to manage risk, so using modern financial and insurance pricing models, especially wang transform and actuarial concepts, ...
15 صفحه اولInvited commentary: heterogeneity of particulate matter health risks.
Ambient particulate matter varies in composition and toxicity; therefore, some heterogeneity in risk per unit mass can be anticipated. In this issue of the Journal (Am J Epidemiol 2007;166:880-888), Dominici et al. explore temporal and spatial effect modification of particulate matter potency with the goal of gaining insights about how differences in the mixture may affect toxicity of the parti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmaceutical Technology in Hospital Pharmacy
سال: 2016
ISSN: 2365-2411,2365-242X
DOI: 10.1515/pthp-2016-0004